Scott Ethridge, PA
Medical · Charleston, WVNPI 1326228552
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,418 of the $15,510 with a category attached, or 86.5%. It is spread thinly across 37 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,622 and has fallen 60.1% since, to $1,842 in 2025. Among medical clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 680 payments — averaging $22.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- AstraZeneca$2K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- Actelion Pharmaceuticals US, Inc.$643
- plus $5K from 31 others
What the payments were for
- Speaking & faculty fees$1,96513%
- Food & beverage$13,41887%
- Education$1271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 70 | $3,406 |
| AstraZeneca(2 entities) | 78 | $1,866 |
| GSK | 116 | $1,597 |
| Regeneron Healthcare Solutions, Inc. | 51 | $1,430 |
| Sanofi | 45 | $1,179 |
| Actelion Pharmaceuticals US, Inc. | 28 | $643 |
| Insmed, Inc. | 35 | $617 |
| Novartis | 30 | $556 |
| Axsome Therapeutics, Inc. | 23 | $519 |
| Mylan Specialty L.p. | 24 | $479 |
| Pulmonx Corporation | 22 | $478 |
| Grifols USA, LLC | 19 | $334 |
| Amgen | 15 | $267 |
| Verona Pharma, Inc. | 11 | $262 |
| Harmony Biosciences LLC | 10 | $246 |
| Genentech USA, Inc. | 17 | $207 |
| United Therapeutics Corporation | 10 | $201 |
| Jazz Pharmaceuticals Inc. | 10 | $185 |
| Baxter Healthcare | 9 | $171 |
| Electromed, Inc. | 20 | $130 |
| Merck | 6 | $94 |
| Mallinckrodt Hospital Products Inc. | 4 | $90 |
| Advanced Respiratory, Inc | 5 | $89 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Vifor Pharma, Inc. | 3 | $66 |
| Eisai Inc. | 3 | $51 |
| Pfizer | 3 | $47 |
| La Jolla Pharmaceutical Company | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Optinose US, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Philips North America LLC | 1 | $15 |
| AbbVie | 1 | $14 |
| Inogen, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,510 in reported general payments places this provider in the 95th percentile of 233 medical providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 266 | $263,012 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 118 | $91,251 |
| Spiriva RespimatTiotropium Bromide | 59 | $56,944 |
| SymbicortBudesonide/Formoterol Fumarate | 128 | $48,138 |
| Breo ElliptaFluticasone/Vilanterol | 64 | $43,277 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 45 | $27,754 |
| Spiriva HandihalerTiotropium Bromide | 27 | $23,491 |
| EliquisApixaban | 32 | $21,897 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 27 | $15,431 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 287 | $13,152 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 39 | $11,254 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $9,058 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $6,575 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 37 | $5,650 |
| BreynaBudesonide/Formoterol Fumarate | 21 | $4,514 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,597 | $328,295372 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,866 | $139,388246 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $3,406 | $84,698104 claims |
| PfizerEliquis | $47 | $21,89732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 233 medical providers in West Virginia.
Other medical in Charleston
- Brandon CaragCharleston$16K
- Mohammad YousafCharleston$9K
- Gregory McCartneyCharleston$9K
- David WatkinsCharleston$5K
- Tara RobinsonCharleston$4K
- Julie StrotherCharleston$3K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.